Henry Esber - Bioxytran Independent Director
| BIXT Stock | USD 0.13 0.02 13.33% |
Director
Dr. Henry J. Esber, Ph.D. serves as Independent Director of the company. He is president and CEO of Argus International, Inc., overseeing a staff of scientists and other professionals who provide consulting services for industry, government agencies, law firms and other organizations, both in the U.S. and internationally. From 2014 to September 15, 2017 Dr. Hoberman served as a member of the board of directors of Boston Therapeutics, Inc. Between 1991 and 2013 he held a series of positions of increasing responsibility at Charles River Laboratories Preclinical Services, most recently as Executive Director of Site Operations and Toxicology. He currently works with that organization to design, supervise and evaluate reproductive and developmental toxicity, neurotoxicity, inhalation and photobiology studies since 2018.
| Age | 78 |
| Tenure | 6 years |
| Phone | 617 454 1199 |
| Web | https://www.bioxytraninc.com |
Bioxytran Management Efficiency
The company has return on total asset (ROA) of (7.0399) % which means that it has lost $7.0399 on every $100 spent on assets. This is way below average. Bioxytran's management efficiency ratios could be used to measure how well Bioxytran manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | DIRECTOR Age | ||
| Brian Corvese | Protagenic Therapeutics | N/A | |
| Khalil Barrage | Protagenic Therapeutics | 50 | |
| Joshua Silverman | Protagenic Therapeutics | 47 | |
| Robert Stein | Protagenic Therapeutics | 65 | |
| Gregory Ekizian | Protagenic Therapeutics | 51 | |
Management Performance
| Return On Asset | -7.04 |
Bioxytran Leadership Team
Elected by the shareholders, the Bioxytran's board of directors comprises two types of representatives: Bioxytran inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioxytran. The board's role is to monitor Bioxytran's management team and ensure that shareholders' interests are well served. Bioxytran's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioxytran's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anders Utter, Independent Director | ||
| Ola Soderquist, CFO, Treasurer, Secretary | ||
| Henry Esber, Independent Director | ||
| CMA CPA, Treasurer CFO | ||
| Michael BS, Chief Officer | ||
| Dale Conaway, Independent Director | ||
| David Platt, President CEO, Director | ||
| Alan Hoberman, Independent Director |
Bioxytran Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Bioxytran a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -7.04 | |||
| Current Valuation | 19.06 M | |||
| Shares Outstanding | 144.64 M | |||
| Shares Owned By Insiders | 65.60 % | |||
| Price To Sales | 532.56 X | |||
| EBITDA | (3.59 M) | |||
| Net Income | (4.04 M) | |||
| Cash And Equivalents | 500.68 K | |||
| Total Debt | 2.17 M | |||
| Current Ratio | 0.09 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bioxytran in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bioxytran's short interest history, or implied volatility extrapolated from Bioxytran options trading.
Pair Trading with Bioxytran
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioxytran position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioxytran will appreciate offsetting losses from the drop in the long position's value.Moving against Bioxytran OTC Stock
| 0.43 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.43 | BA | Boeing Financial Report 24th of July 2024 | PairCorr |
The ability to find closely correlated positions to Bioxytran could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioxytran when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioxytran - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioxytran to buy it.
The correlation of Bioxytran is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioxytran moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioxytran moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioxytran can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioxytran. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Bioxytran OTC Stock analysis
When running Bioxytran's price analysis, check to measure Bioxytran's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioxytran is operating at the current time. Most of Bioxytran's value examination focuses on studying past and present price action to predict the probability of Bioxytran's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioxytran's price. Additionally, you may evaluate how the addition of Bioxytran to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |